Guide Yellow Fever Outbreak 2016
Total Page:16
File Type:pdf, Size:1020Kb
© World Health Organization 2016 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution– should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. Table of contents Introduction Background ............................................................................................................................................... 2 Interactive PDF........................................................................................................................................ 3 Basic communication documents High level Talking Points ........................................................................................................................ 5 Factsheet ................................................................................................................................................... 7 Q&A Yellow fever ................................................................................................................................. 10 Q&A: Yellow fever outbreak in Angola and Democratic Republic of the Congo ....................... 13 Yellow fever vaccine & the ICG Q&A: International Coordinating Group (ICG) on Vaccine Provision ........................................ 16 Infographic on yellow fever supply in an emergency ........................................................................ 19 Lower doses of yellow fever vaccine could be used in emergencies ............................................... 20 RCCE resources and tools Communication and social mobilization in yellow fever mass vaccination campaign 10 points from field experience ........................................................................................................... 23 Risk Communication and Community Engagement (RCCE) Guide Yellow Fever Outbreak 2016 ......................................................................................................................................................... 65 Key response documents Strategic Response Plan for Yellow fever ......................................................................................... 100 Additional documents 1 Background Yellow fever is endemic in tropical areas of Africa and Central and South America. The disease is spread by Aedes aegypti mosquitoes. WHO is particularly concerned about stopping the spread of yellow fever in urban areas where immunization levels are not sufficient (less than 80% of population has immunity) and where mosquitoes are present in high densities. Overcrowded settings with inadequate water supply and waste management services allow the mosquito to breed easily. Since January 2016, a number of you have been involved in the yellow fever outbreak response and/or are planning and preparing to contain the spread of the disease across national borders. Vaccinations are the most effective measures for preventing the disease and cognizant of this, we aknowledge that many of us, including our stakeholders, are not aware of how to quickly access the global stockpile of emergency vaccines for yellow fever. The International Coordinating Group for the Provision of Vaccines (ICG) – a partnership comprised of WHO, UNICEF, Mèdecins sans Frontiéres (MSF) and the International Federation of the Red Cross and Red Crescent Societies (IFRC) – manages the mechanism and accompanying procedures for securing vaccines when insufficient supplies are available within a country. In order to facilitate a better understanding of this mechanism and issues surrounding the coordinated distribution of vaccines to areas that are most in need, we are sending you risk communication and community engagement tools developed for your use as well as for distribution to country counterparts. At page 5 you will find an interactive PDF page containing the guidance and tools on Yellow fever. Click on the icon for the item you wish to read. Any updates will be posted at the same location, so that the interactive PDF remains up-to-date. Please note that the documents are being translated into official WHO languages, commencing with Portuguese, Spanish and French. If you have suggestions on how to improve these products or if you would like to provide any other feedback, please write back to us at [email protected] 2 Interactive PDF 1. YF basic communication documents: Risk communication and community Factsheet on Yellow fever engagement material AR │ CH │ EN │ FR │ RU │ SP │ PT │ Communication and social mobilization in yellow fever Q&A on Yellow fever mass vaccination campaign – 10 points from field experience AR │ CH │ EN │ FR │ RU │ SP │ EN │ FR │ PT │ Q&A on Yellow fever in Angola and Congo AR │ CH │ EN │ FR │RU │ SP │PT │ 4. Key response documents and links Yellow Fever Strategic Response Framework 2. Yellow fever vaccine & the ICG June-August 2016 Q&A on the International Coordinating Group This document, developed with partners including UNICEF and Médecins Sans Frontières, is intended to (ICG) on Vaccine Provision guide the international response to the 2016 outbreak. This document developed with UNICEF provides basic facts about the ICG mechanism to access vaccine EN stockpiles during an emergency. Yellow Fever webpage: EN │PT │ EN Timeline showing the demands on the global Yellow Fever emergency webpage: vaccine supply since early 2016 EN │ FR │ EN │PT │ 5. Additional documents Video explaining how the global vaccine Q&A: Fractional doses of the yellow fever stockpile works vaccine English subtitles – soon available with subtitles in Spanish and Portuguese. EN │ FR │ EN │ FR │ WHO Secretariat information paper - Fractional dose yellow fever vaccine as a dose-sparing Infographic on yellow fever supply in an option for outbreak response emergency EN│PT │ EN Interim technical guidance “Laboratory WHO statement on fractional dosing diagnostic testing in Africa” EN │ FR │PT │ EN │ FR │ PT │ 3. RCCE resources and tools Risk communication and community Email contacts: engagement useful links: 1. Dr Gaya Manori Gamhewage [email protected] 2. Ms Mara Frigo [email protected] EN 3. General email [email protected] 3 Basic communication documents 4 High level Talking Points 04 July 2016 WHO Response in Angola and Democratic Republic of the Congo WHO is concerned about the yellow fever outbreak in Angola and the Democratic Republic of the Congo (DRC) and has been working closely with the Governments and partners on the outbreak response, including supporting vaccination campaigns, strengthening disease surveillance and providing guidance to improve diagnosis and patient care. This is the first time that WHO has activated an Incident Management System for an outbreak response on the ground. WHO's Yellow Strategic Response framework identifies 4 objectives to end the outbreak: o End current outbreaks through vaccination programs o Prevent deaths and illness through early detection and case management o Prevent international spread of the disease o Prioritize yellow fever vaccine research to improve access Vaccination is the key focus of our strategy to control this outbreak. WHO has sent more than 18 million doses to Angola, DRC and Uganda, through the International Coordinating Group global stockpile. This is three times the volume normally expected to be needed in one year for outbreak use and is unprecedented. In the past, the global stockpile has never used more than 4 million doses to control a yellow fever outbreak in a country. Angola has received 15 million doses, DRC 3.2 million doses, Uganda 800 000 doses. WHO has deployed more than 150 experts to support this outbreak and plans to send more teams in the coming weeks. A well-planned additional emergency vaccination campaign is imminent to stop ongoing transmission along border areas between Angola and DRC and in the city of Kinshasa. An immediate priority is to stop the outbreak in Kinshasa DRC by vaccinating around 10 million people, This campaign is likely to start in August